Data gathered: May 29
AI Stock Analysis - Atricure (ATRC)
Analysis generated May 20, 2025. Powered by Chat GPT.
Atricure, Inc. is a leading provider of innovative surgical solutions that enable the treatment of complex cardiac conditions. The company specializes in the development, manufacture, and sale of surgical devices designed to create precision lesions for the treatment of cardiac arrhythmias. With a strong focus on innovation and patient outcomes, Atricure is dedicated to advancing the field of cardiac surgery and improving the quality of life for patients.
Stock Alerts - Atricure (ATRC)
 |
Atricure | May 18 Business Outlook among employees is down by 6.3% over the last month. |
|
Atricure | April 30 Price is down by -10.2% in the last 24h. |
|
Atricure | April 10 Price is down by -5.3% in the last 24h. |
|
Atricure | April 9 Price is up by 7.2% in the last 24h. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Atricure
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 57 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 26,000 | Sign up | Sign up | Sign up |
| Employee Rating | 94 | Sign up | Sign up | Sign up |
| Google Trends | 37 | Sign up | Sign up | Sign up |
| Patents | 150 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 67 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,303 | Sign up | Sign up | Sign up |
| Instagram Followers | 854 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 384 | Sign up | Sign up | Sign up |
| Twitter Followers | 2,637 | Sign up | Sign up | Sign up |
| Twitter Mentions | 7 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 1,130 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 88 | Sign up | Sign up | Sign up |
| Linkedin Employees | 1,282 | Sign up | Sign up | Sign up |
About Atricure
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally.
| Price | $33.54 |
| Target Price | Sign up |
| Volume | 329,330 |
| Market Cap | $1.68B |
| Year Range | $27.02 - $42.4 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Medical & Dental Instruments |
In the news
 |
ProShare Advisors LLC Increases Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)May 28 - ETF Daily News |
|
Man Group plc Invests $745,000 in AtriCure, Inc. (NASDAQ:ATRC)May 26 - ETF Daily News |
|
AtriCure (NASDAQ:ATRC) Stock Rating Upgraded by Wall Street ZenMay 25 - ETF Daily News |
|
Nuveen Asset Management LLC Sells 149,584 Shares of AtriCure, Inc. (NASDAQ:ATRC)May 22 - ETF Daily News |
|
AtriCure, Inc. (NASDAQ:ATRC) Shares Sold by The Manufacturers Life Insurance CompanyMay 17 - ETF Daily News |
|
AtriCure, Inc. (NASDAQ:ATRC) Receives $50.67 Consensus Target Price from AnalystsMay 17 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 124M | 31M | 93M | -6.7M | -6M | -0.140 |
| Q4 '24 | 124M | 32M | 93M | -16M | -9M | -0.080 |
| Q3 '24 | 116M | 29M | 87M | -7.9M | -940,000 | -0.170 |
| Q2 '24 | 116M | 30M | 86M | -8M | -1.6M | -0.170 |
| Q1 '24 | 109M | 28M | 81M | -13M | -7M | -0.280 |
Insider Transactions View All
| Prange Karen filed to sell 17,828 shares at $38.1. March 7 '25 |
| Yuen Maggie filed to sell 8,970 shares at $24.1. August 19 '24 |
| Privitera Salvatore filed to buy 103,290 shares at $22.3. May 31 '24 |
| Noznesky Justin J filed to sell 71,284 shares at $24.1. May 3 '24 |
| Noznesky Justin J filed to sell 72,784 shares at $30.4. April 3 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Align TechnologyALGN |
$180.11 0% | 43 |
 |
DentsplyXRAY |
$16.51 0% | 34 |
 |
LeMaitre VascularLMAT |
$81.01 0% | 48 |
 |
iRhythm TechnologiesIRTC |
$141.37 0% | 50 |
 |
NovoCureNVCR |
$19.37 0% | 51 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Josh Gottheimer |
Aug 15, 24 | Buy | $1K - $15K |
| Josh Gottheimer |
Jul 9, 24 | Sell | $1K - $15K |
Read more about Atricure (ATRC) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Atricure?
The Market Cap of Atricure is $1.68B.
What is the current stock price of Atricure?
Currently, the price of one share of Atricure stock is $33.54.
How can I analyze the ATRC stock price chart for investment decisions?
The ATRC stock price chart above provides a comprehensive visual representation of Atricure's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Atricure shares. Our platform offers an up-to-date ATRC stock price chart, along with technical data analysis and alternative data insights.
Does ATRC offer dividends to its shareholders?
As of our latest update, Atricure (ATRC) does not offer dividends to its shareholders. Investors interested in Atricure should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Atricure?
Some of the similar stocks of Atricure are Align Technology, Dentsply, LeMaitre Vascular, iRhythm Technologies, and NovoCure.
.